Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tsix transcript, Xist antisense RNA (TSIX) is a long non-coding RNA that is transcribed antisense to the Xist gene at the X-inactivation center (XIC) on the X chromosome[2][3]. Its primary role is as a cis-acting negative regulator of Xist expression, thereby controlling the process of X-chromosome inactivation in female mammals. TSIX is expressed from the active X chromosome and prevents Xist upregulation, thereby blocking the initiation of inactivation on that chromosome[3][4]. This antisense RNA is non-protein-coding and functions through mechanisms that may involve chromatin modification and DNA methylation at the Xist promoter[2]. The dynamic and mutually exclusive expression of Tsix and Xist is essential for dosage compensation in female mammals. There is no evidence to date that TSIX is a direct therapeutic target, biomarker, or safety concern.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tsix transcript, Xist antisense RNA (non-protein coding) (TSIX).